Podcasts about Pharmacy

President and chief executive officer of the National Psoriasis Foundation (NPF) Leah M. Howard discusses her article "Pharmacy benefit manager reform vs. direct drug plans." Leah analyzes the recent emergence of direct-purchase drug programs and argues that while innovative thinking is welcome, it cannot replace the need for deep systemic change. She advocates for bipartisan legislative solutions such as the Safe Step Act to address the root causes of high costs in the U.S. health care system rather than relying on siloed fixes that may not help everyone. The conversation emphasizes that true relief for patients with chronic diseases requires transparent pharmacy benefit manager reform and a move away from profit-driven incentives that punish the sick. Join us to learn how we can push for lasting policies that prioritize patient health over corporate profits. This episode is presented by Scholar Advising, a fee-only financial advising firm specializing in providing advice for DIY investors. If you want clear, actionable strategies and confidence that your financial decisions are built on objective advice without AUM fees or commissions, Scholar is designed for you. Physicians often navigate complex compensation structures, including W-2 income, 1099 work, production bonuses, and practice ownership. Scholar's highly credentialed advisors guide high-earners through decisions like optimizing investments for long-term tax efficiency and expert strategies for financial independence. Every recommendation is tailored to the financial realities physicians face. VISIT SPONSOR → https://scholaradvising.com/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this edition of Essential, we've got concerns about the FDA's revolving door, some issues with a new California law that might affects the whole country, and a new accreditation that might save a lot of headache. Then we take a deep dive into the once and future world of compounded peptides — where they are, and where they might be going … and why. Links FDA's revolving door: https://archive.ph/oxBXP  Join APC today: https://a4pc.org/membership  Coalition for Compounding Excellence (CCE) accreditation: https://414uue.share-na2.hsforms.com/2n_hRAnRSQ4O8VteGTesF0Q?_hsenc=p2ANqtz-9rfyq3GuFFZw6omRa96tq_es549FWmjiw-sP5NU3LKrsL1eump-l18h7xVrvy8G_V1Pi4UFkfhARMnPCLIx7TBOwPClQ&_hsmi=394109070 Pharma Source Direct: https://www.linkedin.com/company/pharma-source-direct/

Dive into the career journey of Zach Lewis, CISO and CIO of the University of Health Sciences and Pharmacy, as he explores the intersection of technical resilience and the "human" element of leadership. This episode serves as a tactical guide for navigating the high-stakes world of cybersecurity while staying grounded in curiosity and connection. Key Insights Include: The Power of Curiosity: Why inquisitive hiring is the secret to building high-performing, adaptable teams. Ransomware Reality Checks: Lessons from Lewis's book, Locked Up, on surviving a cyber crisis and coming out stronger. AI's Educational Shift: Understanding how emerging tech is reshaping the classroom and the future job market. Combating Burnout: Practical approaches to sustaining a long-term career in a high-pressure industry. Whether you're looking for leadership strategies in tech or a firsthand account of surviving a ransomware attack, Lewis's blueprint emphasizes that professional success is built on a foundation of authentic relationships. Listen now to discover why intellectual curiosity is the ultimate asset for the modern C-suite leader.

In this episode, podcast co-hosts Dr. Dwight Stoll and Dr. James Grinias talk with Professor Kelly Hines. Dr. Hines is an associate professor in the Department of Chemistry at the University of Georgia in Athens. She received her B.S. degree in Chemistry from the University of Florida, and then completed the Ph.D. in Chemistry at Vanderbilt University. Her doctoral studies focused on monitoring biomolecular signatures of disease via ion mobility and mass spectrometry techniques, and then she moved on to post-doctoral experiences at two different institutions. The first stop was at the metabolomics resource core at the Mayo Clinic, and the second stop was in the Department of Medicinal Chemistry at the University of Washington School of Pharmacy. Kelly has won several awards in the field of chemical analysis, including recognition as a Female Role Model in Analytical Chemistry by Analytical and Bioanalytical Chemistry, as an Emerging Investigator by the Journal of the American Society for Mass Spectrometry, an ASMS Research Award (which is one of the top honors that young investigators in MS can receive), and very recently was named as the Chemist of the Year by the Northeast Georgia Section of the American Chemical Society. In a wide-ranging conversation, we discuss the early origins of Kelly's interest in science rooted in her opportunity to explore the plant nursery managed by her father, and then her turn from civil engineering to analytical chemistry inspired by an early undergraduate course “Chemistry for Engineers”. We discuss Hines' recent and ongoing work involving the use of ion mobility mass spectrometry (IMS-MS), with pre-separation using chromatography when appropriate, for multi-omics studies, aimed at deeper understanding of the biochemistry of organisms at the metabolite level. We also discuss Kelly's positive experiences developing peer networks through regular attendance at conferences, particularly the American Society for Mass Spectrometry (ASMS) annual meeting, experiences in her second post-doctoral position that inspired her to pursue an academic position, and her approach to mentoring graduate students who show up in her laboratory with diverse backgrounds, interests, and abilities.

Wegovy's first weight-loss pill is now available nationwide. Also, experts predict 2026 health trends will focus on expanded GLP-1 use, AI-powered wearable devices, and the “food as medicine” approach. Plus, author Adam Grant discusses how to unlock your hidden potential for greater success. And, NBC turns 100 in 2026, celebrating a century of news, entertainment, and memories. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This is SureCast -- 3-Part Series recorded LIVE  from Nashville, where pharmacy leaders, innovators, and forward-thinking professionals gathered for SureCost Insights 2025: Embracing Pharmacy Evolution, held November 13–14, 2025.    In this episode we hear from: Jessica Daley Josh Hart - OPTU Consulting Matt Gilbert - RxSafe Mike Salazzo - Capital Drug Paul Shelton - LTC@Home

From Wall Street to Main Street, the latest on the markets and what it means for your money. Updated regularly on weekdays, featuring CNBC expert analysis and sound from top business newsmakers. Anchored and reported by CNBC's Jessica Ettinger. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this conversation, career ownership coach Maja Taylor shares powerful insights on what it truly means to take control of your professional future. She talks about helping leaders and professionals explore new career paths, including entrepreneurship, so they can maximize their potential and build careers that fully align with their goals and values. Maja encourages listeners to regularly review their career direction, consider alternative income streams and stay open to possibilities that may lead to greater fulfillment and independence. Employee Engagement and the Need for Better Guidance Michael discusses the growing disconnect many employees feel in today's workplace and highlights how small businesses and leaders can play a pivotal role in guiding their teams toward greater engagement and clarity. He emphasizes the value of career exploration and meaningful conversations that help individuals uncover interests, strengths and untapped potential. Michael also shares personal stories about stepping into new roles without a perfect plan and learning through adaptability, curiosity and experience. Navigating Burnout and Workplace Uncertainty Maja speaks candidly about the rising rates of burnout she sees among clients, driven by layoffs, constant change and market instability. She explains how her coaching practice supports individuals during these challenging transitions by helping them rediscover confidence, purpose and possibility. Maja also reflects on her own journey from science to HR to leadership coaching, revealing how each chapter deepened her passion for helping others achieve greater self sufficiency and work life balance. Corporate Experience as a Launchpad for Entrepreneurship Michael reminds listeners that entrepreneurship is rarely about starting from zero. Skills gained in corporate environments, from operational insight to relationship building, can become powerful assets when launching a business. He encourages people to recognize the value of their existing expertise and leverage it instead of discounting it. Career Coaching for the Shift Into Business Ownership Maja outlines her approach to coaching professionals who are evaluating entrepreneurship, especially those who feel drained by corporate roles or stuck in burnout cycles. She uses assessments to help clients recognize their strengths and potential, and stresses the importance of being open minded as they explore ownership opportunities. Michael adds that many people underestimate their abilities due to work environments that suppress creativity and curiosity. Curiosity as a Catalyst for Breakthroughs Michael shares a personal story about taking a personality assessment with his former CEO and discovering they shared the same profile. The experience reminded him that curiosity is a powerful driver of self awareness and growth. He encourages listeners to lean into curiosity as a tool for breakthroughs, career shifts and life changing clarity. Goal Setting, Reflection and a Free DISC Assessment Maja talks about the impact of written goals, noting that only a small percentage of people write down their goals, yet nearly all who do achieve them. She offers a complimentary executive DISC assessment to help listeners better understand their personality patterns and career strengths. Michael encourages everyone to take advantage of the offer and reminds listeners that Maja's contact information and social links are included in the show notes below.   Maja Taylor is a Career Ownership Coach with The Entrepreneur's Source, where she guides people who are ready to step outside the traditional job market and into new possibilities. She supports clients as they explore entrepreneurship, business ownership, investments, licensing, and franchising, helping them design a career path that aligns with their values, strengths and long term vision. Maja is driven by a deep passion for personal transformation and lifelong learning. She thrives on watching clients experience those pivotal AHA moments when they realize what they are truly capable of. Her mission is to help people rise to their full potential by building careers and businesses that reflect who they are and the life they want to create. With a foundation in science education and talent development, Maja has worked across Europe and the United States in global organizations as a team leader, scientist, strategic HR professional, trainer, coach and mentor. She brings a unique blend of analytical thinking, people development expertise, and business strategy to every client engagement. Her work focuses on helping individuals grow their dreams, wealth and personal equity as they move toward self sufficiency and higher levels of fulfillment and success. Background Overview • Business Owner and Certified Professional Coach • Global Talent, Learning and Engagement roles in Pharma and Biotech • Management consulting experience with Fortune 500 organizations • Scientific and HR leadership roles in manufacturing and environmental industries • Education: BS in Pharmacy, University of Applied Sciences, Wiesbaden, Germany • Credentials: Certified Coach, Human Resources Professional, Leadership Trainer and Facilitator; certified in DiSC, 360 assessments and multiple professional development tools Connect with Maja Website: www.majataylor.esourcecoach.com Email: majataylor@esourcecoach.com LinkedIn: https://www.linkedin.com/in/majataylor/ Facebook: https://www.facebook.com/majataylorcoach Instagram: https://www.instagram.com/majataylorcoach For your audience, add to captions, free offer – DiSC assessment with debrief - a $200 value – if your listeners reach out to me on social media/LI/Insta/FB/ or my website and book a call at www.majataylor.esourcecoach.com

Dr. DebWhat if I told you that the stomach acid medication you’re taking for heartburn is actually causing the problem it’s supposed to solve that your doctor learned virtually nothing about nutrition, despite spending 8 years in medical school. That the very system claiming to heal you was deliberately designed over a hundred years ago by an oil tycoon, John D. Rockefeller, to create lifelong customers, not healthy people. Last week a patient spent thousands of dollars on tests and treatments for acid reflux, only to discover she needed more stomach acid, not less. The medication keeping her sick was designed to do exactly that. Today we’re exposing the greatest medical deception in modern history, how a petroleum empire systematically destroyed natural healing wisdom turned medicine into a profit machine. And why the treatments, keeping millions sick were engineered that way from the beginning. This isn’t about conspiracy theories. This is a documented history that explains why you feel so lost about your own body’s needs welcome back to let’s talk wellness. Now the show where we uncover the root causes of chronic illness, explore cutting edge regenerative medicine, and empower you with the tools to heal. I’m Dr. Deb. And today we’re diving into how the Rockefeller Medical Empire systematically destroyed natural healing wisdom and replaced it with profit driven systems that keeps you dependent on treatments instead of achieving true health. If you or someone you love has been running to the doctor for every minor ailment, taking acid blockers that seem to make digestive problems worse, or feeling confused about basic body functions that our ancestors understood instinctively. This episode is for you. So, as usual, grab a cup of coffee, tea, or whatever helps you unwind. Settle in and let’s get started on your journey to reclaiming your health sovereignty all right. So here we are talking about the Rockefeller Medical Revolution. Now, what if your symptoms aren’t true diagnosis, but rather the predictable result of a medical system designed over a hundred years ago to create lifelong customers instead of healthy people. Now I learned this when I was in naturopathic school over 20 years ago. And it hasn’t been talked about a lot until recently. Recently. People are exposing the truth about what actually happened in our medical system. And today I want to take you back to the early 19 hundreds to understand how we lost the basic health wisdom that sustained humanity for thousands of years. Yes, I said that thousands of years. This isn’t conspiracy theory. This is documented history. That explains why you feel so lost when it comes to your own body’s needs. You know by the turn of the 20th century. According to meridian health Clinic’s documentation. Rockefeller controlled 90% of all petroleum refineries in America and through ownership of the Standard Oil Corporation. But Rockefeller saw an opportunity that went far beyond oil. He recognized that petrochemicals could be the foundation for a completely new medical system. And here’s what most people don’t know. Natural and herbal medicines were very popular in America during the early 19 hundreds. According to Staywell, Copper’s historical analysis, almost one half of medical colleges and doctors in America were practicing holistic medicine, using extensive knowledge from Europe and native American traditions. People understood that food was medicine, that the body had natural healing mechanisms, and that supporting these mechanisms was the key to health. But there was a problem with the Rockefeller’s business plan. Natural medicines couldn’t be patented. They couldn’t make a lot of money off of them, because they couldn’t hold a patent. Petrochemicals, however, could be patented, could be owned, and could be sold for high profits. So Rockefeller and Andrew Carnegie devised a systematic plan to eliminate natural medicine and replace it with petrochemical based pharmaceuticals and according to E. Richard Brown’s comprehensive academic documentation in Rockefeller, medicine men. Medicine, and capitalism in America. They employed the services of Abraham Flexner, who proceeded to visit and assess every single medical school in us and in Canada. Within a very short time of this development, medical schools all around the us began to collapse or consolidate. The numbers are staggering. By 1910 30 schools had merged, and 21 had closed their doors of the 166 medical colleges operating in 19 0, 4, a hundred 33 had survived by 1910 and a hundred 4 by 1915, 15 years later, only 76 schools of medicine existed in the Us. And they all followed the same curriculum. This wasn’t just about changing medical education. According to Staywell’s copper historical analysis. Rockefeller and Carnegie influenced insurance companies to stop covering holistic treatments. Medical professionals were trained in the new pharmaceutical model and natural solutions became outdated or forgotten. Not only that alternative healthcare practitioners who wanted to stay practicing in alternative medicine were imprisoned for doing so as documented by the potency number 710. The goal was clear, create a system where scientists would study how plants cure disease, identify which chemicals in the plants were effective and then recreate a similar but not identical chemical in the laboratory that would be patented. E. Richard Brown’s documents. The story of how a powerful professional elite gained virtual homogeny in the western theater of healing by effectively taking control of the ethos and practice of Western medicine. The result, according to the healthcare spending data, the United States now spends 17.6% of its Gdp on health care 4.9 trillion dollars in 2023, or 14,570 per person nearly twice as much as the average Oecd country. But it doesn’t focus on cure. But on symptoms, and thus creating recurring clients. This systematic destruction of natural medicine explains why today’s healthcare providers often seem baffled by simple questions about nutrition why they immediately reach for a prescription medication for minor ailments, and why so many people feel disconnected from their own body’s wisdom. We’ve been trained over 4 generations to believe that our bodies are broken, and that symptoms are diseases rather than messages, and that external interventions are always superior to supporting natural healing processes. But here’s what they couldn’t eliminate your body’s innate wisdom. Your digestive system still functions the same way it did a hundred years ago. Your immune system still follows the same patterns. The principles of nutrition, movement and stress management haven’t changed. We’ve just forgotten how to listen and respond. We’re gonna take a small break here and hear from our sponsor. When we come back. We’re gonna talk about the acid reflux deception, and why your cure is making you sicker, so don’t go away all right, welcome back. So I want to give you a perfect example of how Rockefeller medicine has turned natural body wisdom upside down, the treatment of acid, reflux, and heartburn. Every single day in my practice I see patients who’ve been taking acid blocker medications, proton pump inhibitors like prilosec nexium or prevacid for years, not for weeks, years, and sometimes even decades. They come to me because their digestive problems are getting worse, not better. They have bloating and gas and nutrition deficiencies. And we’re seeing many more increased food sensitivities. And here’s what’s happening in the Us. Most people often attribute their digestive problems to too much stomach acid. And they use medications to suppress the stomach acid, but, in fact symptoms of chronic acid, reflux, heartburn, or gerd, can also be caused by too little stomach acid, a condition called hyper. Sorry hypochlorhydria normal stomach acid has a Ph level of one to 2, which is highly acidic. Hydrochloric acid plays an important role in your digestion and your immunity. It helps to break down proteins and absorb essential nutrients, and it helps control viruses and bacteria that might otherwise infect your stomach. But here’s the crucial part that most people don’t understand, and, according to Cleveland clinic, your stomach secretes lower amounts of hydrochloric acid. As you age. Hypochlorhydria is more common in people over the age of 40, and even more common over the age of 65. Webmd states that the stomach acid can produce less acid as a result of aging and being 65 or older is a risk factor for developing hypochlorhydria. We’ve been treating this in my practice for a long time. It’s 1 of the main foundations that we learn as naturopathic practitioners and as naturopathic doctors, and there are times where people need these medications, but they were designed to be used short term not long term in a 2,013 review published in Medical News today, they found that hypochlorhydria is the main change in the stomach acid of older adults. and when you have hypochlorydria, poor digestion from the lack of stomach, acid can create gas bubbles that rise into your esophagus or throat, carrying stomach acid with them. You experience heartburn and assume that you have too much acid. So you take acid blockers which makes the underlying problem worse. Now, here’s something that will shock you. PPI’s protein pump inhibitors were originally studied and approved by the FDA for short-term use only according to research published in us pharmacists, most cases of peptic ulcers resolve in 6 to 8 weeks with PPI therapy, which is what these medications were created for. Originally the American family physician reports that for erosive esophagitis. Omeprazole is indicated for short term 4 to 8 weeks. That’s it. Treatment and healing and done if needed. An additional 4 to 8 weeks of therapy may be considered and the University of Minnesota College of Pharmacy, States. Guidelines recommended a treatment duration of 8 weeks with standard once a day dosing for a PPI for Gerd. The Canadian family physician, published guidelines where a team of healthcare professionals recommended prescribing Ppis in adults who suffer from heartburn and who have completed a minimum treatment of 4 weeks in which symptoms were relieved. Yet people are taking these medications for years, even decades far beyond their intended duration of use and a study published in Pmc. Found that the threshold for defining long-term PPI use varied from 2 weeks to 7 years of PPI use. But the most common definition was greater than one year or 6 months, according to the research in clinical context, use of Ppis for more than 8 weeks could be reasonably defined as long-term use. Now let’s talk about what these acid blocker medications are actually doing to your body when used. Long term. The research on long term PPI use is absolutely alarming. According to the comprehensive review published in pubmed central Pmc. Long-term use of ppis have been associated with serious adverse effects, including kidney disease, cardiovascular disease fractures because you’re not absorbing your nutrients, and you’re being depleted. Infections, including C. Diff pneumonia, micronutrient deficiencies and hypomagnesium a low level of magnesium anemia, vitamin, b, deficiency, hypocalcemia, low calcium, low potassium. and even cancers, including gastric cancer, pancreatic cancer, colorectal cancer. And hepatic cancer and we are seeing all of these cancers on a rise, and we are now linking them back to some of these medications. Mayo clinic proceedings published research showing that recent studies regarding long-term use of PPI medication have noted potential adverse effects, including risks of fracture, pneumonia, C diff, which is a diarrhea. It’s a bacteria, low magnesium, low b 12 chronic kidney disease and even dementia. And a 2024 study published in nature communications, analyzing over 2 million participants from 5 cohorts found that PPI use correlated with increased risk of 15 leading global diseases, such as ischemic heart disease. Diabetes, respiratory infections, chronic kidney disease. And these associations showed dose response relationships and consistency across different PPI types. Now think about this. You take a medication for heartburn that was designed for 4 to 8 weeks of use, and when used long term, it actually increases your risk of life, threatening infections, kidney disease, and dementia. This is the predictable result of suppressing a natural body function that exists for important reasons. Hci plays a key role in many physiological processes. It triggers, intestinal hormones, prepares folate and B 12 for absorption, and it’s essential for absorption of minerals, including calcium, magnesium, potassium, zinc, and iron. And when you block acid production, you create a cascade of nutritional deficiencies and immune system problems that often manifest as seemingly unrelated health issues. So what’s the natural approach? Instead of suppressing stomach acid, we need to support healthy acid production and address the root cause of reflux healthcare. Providers may prescribe hcl supplements like betaine, hydrochloric acid. Bhcl is what it’s called. Sometimes it’s called betaine it’s often combined with enzymes like pepsin or amylase or lipase, and it’s used to treat hydrochloric acid deficiency, hypochlorhydria. These supplements can help your digestion and sometimes help your stomach acid gradually return back to normal levels where you may not need to use them all the time. Simple strategies include consuming protein at the beginning of the meal to stimulate Hcl production, consume fluids separately at least 30 min away from meals, if you can, and address the underlying cause like chronic stress and H. Pylori infections. This is such a sore subject for me. So many people walk around with an H. Pylori infection. It’s a bacterial infection in the stomach that can cause stomach ulcers, causes a lot of stomach pain and burning. and nobody is treating the infection. It’s a bacterial infection. We don’t treat this anymore with antibiotics or antimicrobials. We treat it with Ppis. But, Ppis don’t fix the problem. You have to get rid of the bacteria once the bacteria is gone, the gut lining can heal. Now it is a common bacteria. It can reoccur quite frequently. It’s highly contagious, so you can pick it up from other people, and it may need multiple courses of treatment over a person’s lifetime. But you’re actually treating the problem. You’re getting rid of the bacteria that’s creating the issue instead of suppressing the acid. That’s not fixing the bacteria which then leads to a whole host of other problems that we just talked about. There are natural approaches to increase stomach acid, including addressing zinc deficiency. And since the stomach uses zinc to produce Hcl. Taking probiotics to help support healthy gut bacteria and using digestive bitters before meals can be really helpful. This is exactly what I mean about reclaiming the body’s wisdom. Instead of suppressing natural functions, we support them instead of creating drug dependency, we restore normal physiology. Instead of treating symptoms indefinitely, we address the root cause and help the body heal itself. In many cultures. Bitters is a common thing to use before or after a meal. But yet in the American culture we don’t do that anymore. We’ve not passed on that tradition. So very few people understand how to use bitters, or what bitters are, or why they’re important. And these basic things that can be used in your food and cooking and taking could replace thousands of dollars of medication that you don’t really need. That can create many more problems along the way. Now, why does your doctor know nothing about nutrition. Well, I want to address something that might shock you all. The reason your doctor seems baffled when you ask about nutrition isn’t because they’re not intelligent. It’s because they literally never learned this in medical school statistics on nutritional education in medical schools are staggering and help explain why we have such a health literacy crisis in America. According to recent research published in multiple academic journals, only 27% of Us. Medical schools actually offer students. The recommended 25 h of nutritional training across 4 years of medical school. That means 73% of the medical schools don’t even meet the minimum standards set in 1985. But wait, it gets worse. A 2021 survey of medical schools in the Us. And the Uk. Found that most students receive an average of only 11 h of nutritional training throughout their entire medical program. and another recent study showed that in 2023 a survey of more than a thousand Us. Medical students. About 58% of these respondents said they received no formal nutritional education while in medical school. For 4 years those who did averaged only 3 h. I’m going to say this again because it’s it’s huge 3 h of nutritional education per year. So let me put this in perspective during 4 years of medical school most students spend fewer than 20 h on nutrition that’s completely disproportionate to its health benefits for patients to compare. They’ll spend hundreds of hours learning about pharmaceutical interventions, but virtually no time learning how food affects health and disease. Now, could this be? Why, when we talk about nutrition to lower cholesterol levels or control your diabetes, they blow you off, and they don’t answer you. It’s because they don’t understand. But yet what they’ll say is, people won’t change their diet. That’s why you have to take medication. That’s not true. I will tell you. I work with people every single day who are willing to change their diet. They’re just confused by all the information that’s out there today about nutrition. And what diet is the right diet to follow? Do I do, Paleo? Do I do? Aip? Do I do carnivore? Do I do, Keto? Do I do? Low carb? There’s so many diets out there today? It’s confusing people. So I digress. But let’s go back. So here’s the kicker. The limited time medical students do spend on nutrition office often focuses on nutrients think proteins and carbohydrates rather than training in topics such as motivational interviewing or meal planning, and as one Stanford researcher noted, we physicians often sound like chemists rather than counselors who can speak with patients about diet. Isn’t that true? We can speak super high level up here, but we can’t talk basics about nutrition. And this explains why only 14% of the physicians believe they were adequately trained in nutritional counseling. Once they entered practice and without foundational concepts of nutrition in undergrad work. Graduate medical education unsurprisingly falls short of meeting patients, needs for nutritional guidance in clinical practice, and meanwhile diet, sensitive chronic diseases continue to escalate. Although they are largely preventable and treatable by nutritional therapies and dietary. Lifestyle changes. Now think about this. Diet. Related diseases are the number one cause of death in the Us. The number one cause. Yet many doctors receive little to no nutritional education in medical school, and according to current health statistics from 2017 to march of 2020. Obesity prevalence was 19.7% among us children and adolescents affecting approximately 14.7 million young people. About 352,000 Americans, under the age of 20, have been diagnosed with diabetes. Let me say this again, because these numbers are astounding to me. 352,000 Americans, under the age of 20, have been diagnosed with diabetes with 5,300 youth diagnosed with type, 2 diabetes annually. Yet the very professionals we turn to for health. Guidance were never taught how food affects these conditions and what drug has come to the rescue Glp. One S. Ozempic wegovy. They’re great for weight loss. They’re great for treating diabetes. But why are they here? Well, these numbers are. Why, they’re here. This is staggering to put 352,000 Americans under the age of 20 on a glp, one that they’re going to be on for the rest of their lives at a minimum of $1,200 per month. All we have to do is do the math, you guys, and we can see exactly what’s happening to our country, and who is getting rich, and who is getting the short end of the stick. You’ve become a moneymaker to the pharmaceutical industry because nobody has taught you how to eat properly, how to live, how to have a healthy lifestyle, and how to prevent disease, or how to actually reverse type 2 diabetes, because it’s reversible in many cases, especially young people. And we do none of that. All we do is prescribe medications. Metformin. Glp, one for the rest of your life from 20 years old to 75, or 80, you’re going to be taking medications that are making the pharmaceutical companies more wealth and creating a disease on top of a disease on top of a disease. These deficiencies in nutritional education happen at all levels of medical training, and there’s been little improvement, despite decades of calls for reform. In 1985, the National Academy of Sciences report that they recommended at least 25 h of nutritional education in medical school. But a 2015 study showed only 29% of medical schools met this goal, and a 2023 study suggests the problem has become even worse. Only 7.8% of medical students reported 20 or more hours of nutritional education across all 4 years of medical school. This systemic lack of nutrition, nutritional education has been attributed to several factors a dearth of qualified instructors for nutritional courses, since most physicians do not understand nutrition well enough to teach it competition for curriculum time, with schools focusing on pharmaceutical interventions rather than lifestyle medicine and a lack of external incentives that support schools, teaching nutrition. And ironically, many medical schools are part of universities that have nutrition departments with Phd. Trained professors who could fill this gap by teaching nutrition in medical schools but those classes are often taught by physicians who may not have adequate nutritional training themselves. This explains so much about what I see in my practice. Patients come to me confused and frustrated because their primary care doctors can’t answer basic questions about how food affects their health conditions. And these doctors aren’t incompetent. They simply were never taught this information. And the result is that these physicians graduate, knowing how to prescribe medications for diabetes, but not how dietary changes can prevent or reverse it. They can treat high blood pressure with pharmaceuticals, but they may not know that specific nutritional approaches can be equally or more effective. This isn’t the doctor’s fault. It’s the predictable result of medical education systems that was deliberately designed to focus on patentable treatments rather than natural healing approaches. And remember this traces back to the Rockefeller influence on medical education. You can’t patent an apple or a vegetable. But you can patent a drug now. Why can’t we trust most medical studies? Well this just gets even better. I need to address something that’s crucial for you to understand as you navigate health information. Why so much of the medical research you hear about in the news is biased, and why peer Review isn’t the gold standard of truth you’ve been told it is. The corruption in medical research by pharmaceutical companies is not a conspiracy theory. It’s well documented scientific fact, according to research, published in frontiers, in research, metrics and analytics. When pharmaceutical and other companies sponsor research, there is a bias. A systematic tendency towards results serving their interests. But the bias is not seen in the formal factors routinely associated with low quality science. A Cochrane Review analyzed 75 studies of the association between industry, funding, and trial results, and these authors concluded that trials funded by a drug or device company were more likely to have positive conclusions and statistically significant results, and that this association could not be explained by differences in risk of bias between industry and non-industry funded trials. So think about that. According to the Cochrane collaboration, industry funding itself should be considered a standard risk of bias, a factor in clinical trials. Studies published in science and engineering ethics show that industry supported research is much more likely to yield positive outcomes than research with any other sponsorship. And here’s how the bias gets introduced through choice of compartor agents, multiple publications of positive trials and non-publication of negative trials reinterpreting data submitted to regulatory agencies, discordance between results and conclusions, conflict of interest leading to more positive conclusions, ghostwriting and the use of seating trials. Research, published in the American Journal of Medicine. Found that a result favorable to drug study was reported by all industry, supported studies compared with two-thirds of studies, not industry, supported all industry, supported studies showed favorable results. That’s not science that’s marketing, masquerading as research. And according to research, published in sciencedirect the peer review system which we’re told ensures quality. Science has a major limitation. It has proved to be unable to deal with conflicts of interest, especially in big science contexts where prestigious scientists may have similar biases and conflicts of interest are widely shared among peer reviewers. Even government funded research can have conflicts of interest. Research published in pubmed States that there are significant benefits to authors and investigators in participating in government funded research and to journals in publishing it, which creates potentially biased information that are rarely acknowledged. And, according to research, published in frontiers in research, metrics, and analytics, the pharmaceutical industry has essentially co-opted medical knowledge systems for their particular interests. Using its very substantial resources. Pharmaceutical companies take their own research and smoothly integrate it into medical science. Taking advantage of the legitimacy of medical institutions. And this corruption means that much of what passes for medical science is actually influenced by commercial interests rather than pursuant of truth. Research published in Pmc. Shows that industry funding affects the results of clinical trials in predictable directions, serving the interests of the funders rather than the patients. So where can we get this reliable, unbiased Health information, because this is critically important, because your health decisions should be based on the best available evidence, not marketing disguised as science. And so here are some sources that I recommend for trustworthy health and nutritional information. They’re independent academic sources. According to Harvard Chan School of public health their nutritional, sourced, implicitly states their content is free from industry, influence, or support. The Linus Pauling Institute, Micronutrient Information Center at Oregon State University, which, according to the Glendale Community college Research Guide provides scientifically accurate information about vitamins, minerals, and other dietary factors. This Institute has been around for decades. I’ve used it a lot. I’ve gotten a lot of great information from them. Very, very trustworthy. According to the Glendale Community College of Nutrition Resource guide Tufts, University of Human Nutritional Research Center on aging is one of 6 human nutrition research centers supported by the United States Department of Agriculture, the Usda. Their peer reviewed journals with strong editorial independence though you must still check funding resources. And how do you evaluate this information? Online? Well, according to medlineplus and various health literacy guides when evaluating health information medical schools and large professional or nonprofit organizations are generally reliable sources, but remember, it is tainted by the Rockefeller method. So, for example, the American College of cardiology. Excuse me. Professional organization and the American Heart Institute a nonprofit are both reliable sources. Sorry about that of information on heart health and watch out for ads designed to look like neutral health information. If the site is funded by ads they should be clearly marked as advertisements. Excuse me, I guess I’m talking just a little too much now. So when the fear of medicine becomes deadly. Now, I want to address something critically important that often gets lost in conversations about health, sovereignty, and questioning the medical establishment. And while I’ve spent most of this episode explaining how the Rockefeller medical system has created dependency and suppressed natural healing wisdom. There’s a dangerous pendulum swing happening that I see in my practice. People becoming so fearful of pharmaceutical interventions that they refuse lifesaving treatments when they’re genuinely needed. This is where balance and clinical judgment become absolutely essential. Yes, we need to reclaim our basic health literacy and reduce our dependency on unnecessary medical interventions. But there are serious bacterial infections that require immediate antibiotic treatment, and the consequences of avoiding treatment can be devastating or even fatal. So let me share some examples from research that illustrate when antibiotic fear becomes dangerous. Let’s talk about Lyme disease, and when natural approaches might not be enough. The International Lyme Disease Association ilads has conducted extensive research on chronic lyme disease, and their findings are sobering. Ileds defines chronic lyme disease as a multi-system illness that results from an active and ongoing infection of pathogenic members of the Borrelia Brdorferi complex. And, according to ilads research published in their treatment guidelines, the consequences of untreated persistent lyme infection far outweigh the potential consequences of long-term antibiotic therapy in well-designed trials of antibiotic retreatment in patients with severe fatigue, 64% in the treatment arm obtained clinically significant and sustained benefit from additional antibiotic therapy. Ilas emphasizes that cases of chronic borrelia require individualized treatment plans, and when necessary antibiotic therapy should be extended their research demonstrates that 20 days of prophylactic antibiotic treatment may be highly effective for preventing the onset of lyme disease. After known tick bites and patients with early Lyme disease may be best served by receiving 4 to 6 weeks of antibiotic therapy. Research published in Pmc. Shows that patients with untreated infections may go on to develop chronic, debilitating, multisystem illnesses that is difficult to manage, and numerous studies have documented persistent Borrelia, burgdorferi infection in patients with persistent symptoms of neurological lyme disease following short course. Antibiotic treatment and animal models have demonstrated that short course. Antibiotic therapy may fail to eradicate lyme spirochetes short course is a 1 day. One pill treatment of doxycycline. Or less than 20 days of antibiotics, is considered a short course. It’s not long enough to kill the bacteria. The bacteria’s life cycle is about 21 days, so if you don’t treat the infection long enough, the likelihood of that infection returning is significant. They’ve also done studies in the petri dish, where they show doxycycline being put into a petri dish with active lyme and doxycycline does not kill the infection, it just slows the replication of it. Therefore, using only doxycycline, which is common practice in lyme disease may not completely eradicate that infection for you. So let’s talk about another life threatening emergency. C. Diff clostridia difficile infection, which represents another example where antibiotic treatment is absolutely essential, despite the fact that C diff itself is often triggered by antibiotic use. According to Cleveland clinic C. Diff is estimated to cause almost half a million infections in the United States each year, with 500,000 infections, causing 15,000 deaths each year. Studies reported by Pmc. Found thirty-day Cdi. Mortality rates ranging from 6 to 11% and hospitalized Cdi patients have significantly increased the risk of mortality and complications. Research published in Pmc shows that 16.5% of Cdi patients experience sepsis and that this increases with reoccurrences 27.3% of patients with their 1st reoccurrence experience sepsis. While 33.1% with 2 reoccurrences and 43.2% with 3 or more reoccurrences. Mortality associated with sepsis is very high within hospital 30 days and 12 month mortality rates of 24%, 30% and 58% respectively. According to the Cdc treatment for C diff infection usually involves taking a specific antibiotic, such as vancomycin for at least 10 days, and while this seems counterintuitive, treating an antibiotic associated infection with more antibiotics. It’s often lifesaving. Now let’s talk about preventing devastating complications. Strep throat infections. Provide perhaps the clearest example of when antibiotic treatment prevents serious long-term consequences, and, according to Mayo clinic, if untreated strep throat can cause complications such as kidney inflammation and rheumatic fever. Rheumatic fever can lead to painful and inflamed joints, and a specific type of rash of heart valve damage. We also know that strep can cause pans pandas, which is a systemic infection, often causing problems with severe Ocd. And anxiety and affecting mostly young people. The research is unambiguous. According to the Cleveland clinic. Rheumatic fever is a rare complication of untreated strep, throat, or scarlet fever that most commonly affects children and teens, and in severe cases it can lead to serious health problems that can affect your child’s heart. Joints and organs. And research also shows that the rate of development of rheumatic fever in individuals with untreated strep infections is estimated to be 3%. The incidence of reoccurrence with a subsequent untreated infection is substantially greater. About 50% the rate of development is far lower in individuals who have received antibiotic treatment. And according to the World health organization, rheumatic heart disease results from the inflammation and scarring of the heart valves caused by rheumatic fever, and if rheumatic fever is not treated promptly, rheumatic heart disease may occur, and rheumatic heart disease weakens the valves between the chambers of the heart, and severe rheumatic heart disease can require heart surgery and result in death. The who states that rheumatic heart disease remains the leading cause of maternal cardiac complications during pregnancy. And additionally, according to the National Kidney foundation. After your child has either had throat or skin strep infection, they can develop post strep glomerial nephritis. The Strep bacteria travels to the kidneys and makes the filtering units of the kidneys inflamed, causing the kidneys to be able to unable or less able to fill and filter urine. This can develop one to 2 weeks after an untreated throat infection, or 3 to 4 weeks after an untreated skin infection. We need to find balance. And here’s what I want you to understand. Questioning the medical establishment and developing health literacy doesn’t mean rejecting all medical interventions. It means developing the wisdom to know when they’re necessary and lifesaving versus when they’re unnecessary and potentially harmful. When I see patients with confirmed lyme disease, serious strep infections or life. Threatening conditions like C diff. I don’t hesitate to recommend appropriate therapy but I also work to support their overall health address, root causes, protect and restore their gut microbiome and help them recover their natural resilience. The goal isn’t to avoid all medical interventions. It’s to use them wisely when truly needed, while simultaneously supporting your body’s inherent healing capacity and addressing the lifestyle factors that created the vulnerability. In the 1st place. All of this can be extremely overwhelming, and it can be frightening to understand or learn. But remember, the power that you have is knowledge. The more you learn about what’s actually happening in your health, in understanding nutrition. in learning what your body wants to be fed, and how it feels, and working with practitioners who are holistic in nature, natural, integrative, functional, whatever we want to call that these days. The more you can learn from them, the more control you have over your own health and what I would urge you to do is to teach your children what you’re learning. Teach them how to live a healthy lifestyle, teach them how to keep a clean environment. This is how we take back our own health. So thank you for joining me today on, let’s talk wellness. Now, if this episode resonated with you. Please share it with someone who could benefit from understanding how the Rockefeller medical system has shaped our approach to health, and how to reclaim your body’s wisdom while using medical care appropriately when truly needed. Remember, wellness isn’t just about feeling good. It’s about understanding your body, trusting its wisdom, supporting its natural healing capacity, and knowing when to seek appropriate medical intervention. If you’re ready to explore how functional medicine can help you develop this deeper health knowledge while addressing root causes rather than just managing symptoms. You can get more information from serenityhealthcarecenter.com, or reach out directly to us through our social media channels until next time. I’m Dr. Dab, reminding you that your body is your wisest teacher. Learn to listen, trust the process, use medical care wisely when needed, and take care of your body, mind, and spirit. Be well, and we’ll see you on the next episode.The post Episode 250 -The Great Medical Deception first appeared on Let's Talk Wellness Now.

The second half of 2025 brought a different kind of energy to Any Given Runday from race-day nerves and strategies, post marathon blues and pitfalls, big challenges, and honest conversations about what really goes into endurance sport.From first time marathoners to elite athletes, to caffeine, strength work, climbing the tallest peaks in the world, and ballsy strategies to endurance challenges, this episode captures some the lessons and the craic on the podcast from July through December.Whether you're deep in winter training, recovering from a big year, or already eyeing your next start line, this Best Of is a reminder that progress doesn't come from one perfect session, it comes from showing up, learning, and staying curious.Thanks again for making 2025 our biggest year yet. This one's for the runners, the thinkers, and the ones still figuring it out.2:01 Anne & Jamie on what to expect on Dublin Marathon morning5:49 The Fantastic 4, with Cliodhna on signing up for her first ever marathon10:46 Rob Dwyer, who does lane swimming on a Monday11:15 Niamh Culhane on caffeine and performance: benefits, timing, and pitfalls18:50 Learning about The Speed Project and the lads' ballsy approach to it25:55 Sarah Kelly on why women's training is different and how research lagged behind on purpose34:10 Mick Fox's Dublin Marathon approach from our first-ever YouTube Live episode38:55 Kevin English with post marathon advice most runners ignore45:51 Will Boyle on the turning point that started his running journey55:37 Enda Kilgallon breaks down the strength exercises runners should actually be doing63:24 Andy Nolan on why Denali was the hardest peak he's climbed so farYou can follow us on Instagram:@anygivenrundaypodcastYou can now get 20% off all Perform Nutrition products, including their new Electrolytes+, using the code 'AGR' at checkoutPerformNutrition.com This episode is sponsored by ULTRAPURE Laboratories and their Ultrapure Sports Recovery prducts. Ask for the ULTRAPURE Laboratories Muscle Recovery range in your local Pharmacy or Health Store or visit their new online storeUltrapurelabs.ie

Listen in as our expert panel discusses evidence-based approaches to help patients quit smoking, vaping, and using other nicotine products. You'll gain practical insights on medication selection, combination strategies, and tailored approaches for helping patients break free from nicotine addiction.Special guest:Robin Corelli, PharmD, CTTS, FCSHPProfessor of Clinical PharmacySchool of PharmacyUniversity of California, San FranciscoYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in November 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Smoking Cessation Drug TherapyFAQ: E-Cigarettes and VapingChart: Dos and Don'ts With PatchesArticle: Help Patients Send Their Vaping Habits Up in Smoke Use code mt1026 at checkout for 10% off a new or upgraded subscription.Send us a textEmail us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. Learn more about our product offerings at trchealthcare.com.

Today we are joined once more by the renowned herbalist and author Robert Dale Rogers. Known for his extensive research on mushrooms and lichens, Robert is here to discuss the fascinating world of ferns and his latest book, 'The Fern Pharmacy.' We explore the medicinal wonders of ferns, discover their unique lifecycles, and learn some surprising historical and practical uses. Robert shares insights from his journey and research, including the importance of proper preparation for medicinal efficacy and his personal experiences with various fern species. Whether you're an herbalist looking to expand your knowledge or just curious about the hidden potentials of these ancient plants, this episode offers a wealth of information. Stay tuned as Robert also teases his upcoming works on mosses and medicinal cacti. 00:00 Introduction to the Plant Cunning Podcast00:31 Welcoming Robert Dale Rogers01:41 Researching the Fern Pharmacy03:56 Ferns in History and Culture06:30 Medicinal and Edible Ferns17:02 Practical Uses of Ferns20:44 Ferns in Traditional Medicine23:06 Decoctions and Infusions: Using Ferns for Health23:46 Traditional Uses of Ferns in Indigenous Medicine25:15 Favorite Ferns and Their Medicinal Benefits28:24 Ferns in Global Practices and Personal Anecdotes34:37 Silica and Bone Health: The Role of Ferns36:26 Upcoming Projects and Future Research

In this episode, our guest is Mary V. Relling, Pharm.D. Emerita Member, Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Dr. Relling earned her undergraduate B.S. degree from the University of Arizona College of Pharmacy and her doctoral degree from the University of Utah College of Pharmacy. She completed post-doctoral fellowships with Dr. William Evans at St. Jude and with Dr. Urs Meyer at University of Basel. She joined St. Jude as a faculty member in 1988, and was chair ofthe Department of Pharmaceutical Sciences from 2003-2020. She was also a professor at the University of Tennessee in the Colleges of Medicine and Pharmacy. Her primary interests are in the treatment and pharmacogenetics of childhood leukemia and in the clinical implementation of pharmacogenetic testing in medicine. Dr. Relling is co-founder of CPIC, the Clinical Pharmacogenetics Implementation Consortium. She has published over 450 original scientific manuscripts. She was elected to the Institute of Medicine (National Academy of Medicine) in 2009.Topics to discuss:Foundations & Career JourneyYou've had an extraordinary career at St. Jude since joining in 1988. What first drew you to pediatric pharmacology and pharmacogenetics?Your work has helped shape how we treat childhood leukemia. What do you see as the most transformative advancements in this space over your career?Pharmacogenetics & CPICYou co-founded the Clinical Pharmacogenetics Implementation Consortium (CPIC). What was the impetus behind its creation, and how has its mission evolved?What do you see as the biggest barriers to widespread clinical implementation of pharmacogenetic testing today?How do you respond to skepticism about the clinical utility of pharmacogenetic testing in everyday medical practice?Which pharmacogenetic guidelines do you believe have had the most significant clinical impact so far—and why?What advice do you have for institutions that want to start implementing pharmacogenetic testing but don't know where to begin?Implementation in Clinical SettingsAt St. Jude, you helped lead efforts to integrate pharmacogenetic testing into clinical care. What lessons did you learn about operationalizing this work in real-world settings?How important is interdisciplinary collaboration—between pharmacists, physicians, geneticists—in making pharmacogenetic testing work in practice?Can you share an example where pharmacogenetic testing changed the course of treatment for a pediatric patient?Policy, Ethics, and Future VisionWhat policy or regulatory changes would help accelerate the clinical adoption of pharmacogenetic testing?As someone who has contributed extensively to the science, how do you think we should balance data privacy with the need for clinical data sharing in genomics?What are you most excited about in the future of pharmacogenetics? Are there particular therapeutic areas or technologies that you think will drive the next wave of innovation?Legacy & AdviceYou've mentored many rising leaders in the field. What qualities do you think are most important for the next generation of pharmacogenomics researchers and clinicians?With over 450 publications and a career that has changed pediatric pharmacology, what legacy do you hope your work leaves behind?Guest: Mary V. Relling, Pharm.D. Emerita Member, Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research HospitalHost: Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/  ★ Support this podcast on Patreon ★

Minister of Climate Change and Environmental Coordination Dr. Musadiq Malik comes on the Pakistan Experience to discuss the Floods, Climate Change, Early Warning Systems, the Hybrid Regime, Balochistan, PTI vs the Writ of the State, Imran Khan's sisters being mishandled, deforestation, accountability, electric vehicles, and more.Dr. Musadik Malik holds a BS in Pharmacy from the University of the Punjab.He then went to University of Illinois, where he earned an MBA, an M.S. and a Ph.D. in Healthcare Administration and Policy.In addition, he completed a post-doctoral fellowship in Health Economics and Medical Decision Making at the University of Illinois College of Medicine.The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Karachi and Motorways6:38 Climate Change, Housing Societies and RUDA25:00 Floods, Early Warning Systems and GLOF34:00 RUDA and Flood prevention Systems44:00 Deforestation, Cutting Trees and Accountability 52:10 Siyaasi Majbooriyan and Petroleum 1:02:12 Balochistan and the Hybrid Regime1:19:00 Military Courts, Institution Strengthening and Writ of the State1:29:40 Imran Khan's sisters being manhandled and writ of the state1:35:20 Gandapur and PTI's incitement to violence1:40:15 Audience Questions

Pharmacy buyers play a critical role in keeping hospitals running—and their partnership with a GPO can make all the difference. In this episode of Verified Rx, Jackie Stokes sits down with Theresa Brown and Michelle Crump, two powerhouse pharmacy buyers and members of Vizient's Pharmacy Technician Committee, to talk about the tools, programs, and peer networks that help them thrive in their roles. From leveraging pharmacy analytics to navigating shortages, maximizing NovaPlus value, and strengthening buyer-to-buyer collaboration, this episode is packed with insights to help pharmacy teams work smarter, save money, and support better patient care.   Guest speakers:  Theresa Brown National Pharmacy Purchasing Specialist Prospect Medical Holdings   Michelle Crump, ASBA, CPhT National Certified Pharmacy Technician Buyer Pharmacy Host: Jackie Stokes Program Services Manager Center for Pharmacy Practice Excellence (CPPE) Vizient   Show Notes: [00:48] — Guest Introductions Theresa National pharmacy purchasing specialist Background: inventory control, home infusion startup, pharmacy technician educator [01:14] — Michelle Nationally certified pharmacy technician since 2016 Pharmacy buyer at a small independent county critical access hospital Transitioned from accounting into pharmacy purchasing   [01:26] — The Role of Vizient in Supporting Pharmacy Buyers Theresa: Biggest benefit: relationship with pharmacy executive & sourcing team Uses Pharmacy Analytics (formerly VSAP) to evaluate spend and inventory control across 63 facilities   [02:16] — How Pharmacy Analytics Supports Buyers Theresa: Data mining on spend increases/decreases Tracks product returns Identifies sharing opportunities to prevent waste [02:59] — Michelle's Experience Analytics helps mitigate waste Collaboration with other buyers has been essential — especially for someone new to the buyer role Learns navigation of Vizient systems and how to work with the local GPO Peer support helps demystify a “diverse and complex” buyer role   [04:02] — Value of the Vizient Pharmacy Technician Committee Provides national peer networking Helps buyers learn from subject matter experts Even highly experienced buyers (35+ years) learn from every call   [04:41] — Vizient Programs: NovaPlus, NES, Forum Calls, Hot Info Bimonthly Forum Calls Provide regulatory updates Help expand buyer knowledge in real time Hot Info Weekly Updates Keeps users informed on inventory, shortages, spend impacts [05:31] — Michelle on Program Impact Calls and shared expertise were critical when she was new NovaPlus program especially valuable in critical access settings   [06:32] — Deep Dive: How the NovaPlus Program Works Michelle explains: NovaPlus (Y-label) aligns with manufacturer-labeled products (M-label) Quarterly rebates provide significant savings Critical access hospitals benefit via 340B optimizer software that extracts outpatient utilization to qualify for discounted M-label purchasing Can result in “significant savings” depending on contract structure   [08:38] — What If NovaPlus Pricing Isn't the Best Price? Michelle: Buyer's responsibility to identify price discrepancies Communicates with Vizient representative to reassess contracting needs Often resolved through rebates or future price adjustments [09:30] — Theresa: Price challenges taken seriously Many result in price reductions visible in Hot Info the next week Demonstrates importance of strong GPO relationships   [10:07] — Understanding NES: NovaPlus Enhanced Supply Theresa: Her hospitals are exploring NES participation Requires 90% compliance (higher than standard 80%) Benefits include prioritized product access during shortages Critical when national backorders exceed 200+ items Ensures better patient care continuity   [11:34] — Supply Assurance & Mitigation Strategies Michelle: During the North Carolina hurricane, Vizient's mitigation strategy was “imperative” Vizient engaged Baxter directly to resolve critical fluid shortages Small hospitals especially reliant on support in crisis situations [12:36] — Theresa: Shortage team provides substitution guidance and clinical appropriateness information Vizient recommendations support discussions with local clinical teams Crucial during COVID start date — her first day in national role   [13:23] — Continuing Education (CE) Programs Theresa: Vizient CE programs help maintain technician licensure Webinars are interactive, engaging, and more informative than generic CE resources   [14:07] — Networking and Pharmacy Aggregation Groups (PAGs) Theresa: PAGs offer cost savings and peer collaboration Ability to share information and bring value back to her own network [14:44] — Michelle's Example of System-to-System Collaboration Shared compounded syringes (from a 503B facility) with another hospital to prevent waste Highlights real-world benefits of PAG networking   [15:52] — Addressing National Challenges Together Theresa: PAG roundtables help uncover shared struggles (e.g., DSCSA serialization issues) Members provide actionable advice on what's working in their systems Reinforces “we're all in the same boat”   [16:50] — Supporting and Elevating Pharmacy Technicians Jackie's goal: Support technicians and recognize the value they bring Committee exists to uplift and empower pharmacy buyers/techs [17:05] — Michelle: Worked with leadership to create a tiered technician level system Helps techs gain skills, feel valued, and earn raises Improves career satisfaction and retention   [17:46] — Closing Reflections Theresa: Being part of Vizient is “an honor and a privilege” Values shared knowledge and strong relationships [18:00] — Michelle: Gratitude for collaboration and guidance over the years Vizient connections were vital for adapting to the buyer role   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

This episode of the Pharmacy Quality Solutions (PQS) Quality Corner Show features host Nick Dorich and returning guest Jesse McCullough, founder of Keystone Pharmacy Insights. Together, they reflect on the evolving landscape of pharmacy in 2025, focusing on the critical need for continuous learning and interpersonal leadership. The discussion centers on the idea that in a rapidly changing healthcare environment, staying stagnant is equivalent to falling behind. Key takeaways cover: The Power of Personal Connection, The Learner's Mindset, A New Definition of Competition, and Clinical EmpathyHow to contact Jesse McCullough and Keystone Insights:LinkedInFacebookSkool

2025 Highlights: The Doctor of Connections & Building Momentum for 2026Guest: Theresa Benvenuto, Doctor of ConnectionsHost: Julie RigaEpisode Type: Special Holiday Edition - Year in ReviewOverviewIn this special holiday edition, Julie sits down with Theresa Benvenuto (affectionately known as "Benvenuts" and the "Doctor of Connections") to reflect on an extraordinary year of growth, transformation, and meaningful relationships. Together, they celebrate the wins, share lessons learned, and look ahead to the opportunities awaiting in 2026. This episode is a heartwarming reminder that success isn't just about what you achieve. It's about who you become and the connections you nurture along the way.2025 Highlights: The Doctor of Connections & Building Momentum for 2026About This EpisodeJulie and Theresa reflect on an extraordinary 2025 filled with networking adventures, leadership growth, and meaningful transformations. From the Vault Conference to building the Before I Lead program, they share behind-the-scenes stories and remind us that the sweetness of business lies in the relationships we build.Guest BackgroundTheresa Benvenuto brings 20+ years of pharmaceutical experience into her second career as a business development specialist and connector extraordinaire. Her nickname "Doctor of Connections" reflects her gift for getting people "Directly On Calendar" (DOC) and creating meaningful business relationships that lead to transformation.Fun Fact: Theresa's favorite holiday cookie is the Christmas Tree, an Italian S-cookie from her grandmother's recipe that she makes every year in her memory.Key TopicsThe Birth of "Doctor of Connections": How Theresa's identity evolved from Doctor of Pharmacy to Doctor of Connections, capturing her passion for business development and networking.2025 Highlights:The Vault Conference in FloridaBuilding the Before I Lead ProgramThe Before I Sell Initiative and LinkedIn strategyEpic Networking Group and holiday networking eventsThe Power of Accountability: How the Before I Lead program provides leaders with accountability that accelerates growth and proves that prospecting work done today shows results 30 days later.Memorable Quotes"We planted a lot of seeds this year, and our plants and roses and beautiful flowers are gonna grow in 2026.""We get lost in the flurry of all the work that we have to do that we forget the sweetness of business. And the sweetness of business is the relationships that we build.""If I can help you change the way you're doing something that is plaguing you, then I've done my job."Key TakeawaysRelationships Are the Sweetness of Business - Prioritize authentic connection over tasksAccountability Accelerates Growth - Join groups that challenge your limiting beliefsThe 30-Day Rule Works - Consistent prospecting today creates results in 30 daysChallenge Your Stories - Rewrite the narratives holding you backInvest in Yourself First - Make your growth a non-negotiable investmentNetwork with Purpose - Show up authentically everywhereAha Moments Change Everything - Stay open to transformationConnectTheresa Benvenuto: Doctor of Connections specializing in Business Development, LinkedIn Strategy, and NetworkingJulie Riga: Leadership Coach offering Before I Lead programHoliday Wishes: Happy Hanukkah, Merry Christmas, Happy New Year! Here's to a healthy, purposeful, and transformational 2026. Stay on course!

Following the death of a 22-year-old who couldn’t afford a sudden price hike for his asthma medication, state lawmakers are advancing legislation to reform how prescription drugs are priced and managed in Wisconsin. The “Cole’s Act” was inspired by an Appleton man who went to pick up a routine inhaler only to find the price had jumped from $66 to $539. Choosing to pay his rent instead of the price at the counter, he passed away from an asthma attack just days later. The bill aims to prevent such tragedies by requiring a 90-day notification for price changes and preventing insurers from dropping drug coverage mid-plan. Beyond consumer protections, the bill targets Pharmacy Benefit Managers (PBMs), which, co-sponsor Sen. Howard Marklein says, are squeezing rural independent pharmacies out of business.See omnystudio.com/listener for privacy information.

The first half of 2025 gave us some of the most honest, inspiring and downright interesting conversations we've had on Any Given Runday.From survival stories on the far side of the world, to elite endurance insights, to everyday decisions that shape how we train, fuel and think — this episode pulls together some of the standout moments from the first six months of the year.Whether you're switching off over the holidays, sneaking in an easy run, or already plotting what 2026 might look like, this is a chance to rewind, reflect, and catch anything you might have missed.Thank you for making 2025 our biggest year yet. We really appreciate every listen, share and message, and we hope you enjoy this Best Of Any Given Runday.1:27 Fergal Guihen on being drugged in Iran — and the strangers who helped him continue a 23,000km cycle to Australia11:29 Becky Woods on sibling rivalry, identity, and finding her place in Ironman24:04 Ger Copeland on training principles behind 300+ marathons, many under 3 hours32:05 Niamh Fitzpatrick on why sea swimming is non-negotiable for ultra runners35:43 Cian Charlton on breaking the sub-20 minute 5K and beyond42:22 Gary Reinhardt on why he stopped running with AirPods46:24 Dr Aisling Farrell on social media, fad diets, and avoiding common traps56:34 John O'Regan on the rise of endurance racing in IrelandYou can follow us on Instagram:@anygivenrundaypodcastYou can now get 20% off all Perform Nutrition products, including their new Electrolytes+, using the code 'AGR' at checkoutPerformNutrition.com This episode is sponsored by ULTRAPURE Laboratories and their Ultrapure Sports Recovery prducts. Ask for the ULTRAPURE Laboratories Muscle Recovery range in your local Pharmacy or Health Store or visit their new online storeUltrapurelabs.ie

Most pharmacies lose thousands monthly by treating CCM and RPM as competing services instead of complementary revenue streams. The difference between profitable programs and claim denials primarily stems from documentation boundaries, time allocation rules, and an understanding of billing codes.Learn more: https://ccmrpmhelp.com/contact CCM RPM Help City: Herriman Address: 12953 Penywain Lane Website: https://ccmrpmhelp.com/ Phone: +1 866 574 7075 Email: brad@ccmrpmhelp.com

We're continuing our look back at some of the most important For the People segments of 2025 and we'll start with: Preservation Connecticut - which turned 50 this year. Tune in and check out how they're going to continue sustaining and preserving critical buildings, sites, even social and cultural practices that helped shape the state we live in. Then we'll replay our visit with the Women's Mentoring Network. This nonprofit serving Fairfield County and beyond, is providing foundational skills for individuals to secure better employment options and encouraging individuals to seek educational opportunities as they look to become economically empowered.   And we'll close replaying our introduction of Art Pharmacy - an organization becoming active in Connecticut enabling personalized social prescribing services with healthcare, university, corporate, and government partners to address the nation's most intractable health challenges.

In this episode of Data in Biotech, Ross Katz chats with Jaidev Chakka, Principal Scientist at the University of Mississippi School of Pharmacy, about how 3D bioprinting and AI are reshaping pharmaceutical manufacturing. They explore the development of custom scaffolds for tissue engineering, the integration of gene delivery systems, and how data-driven approaches are enabling smarter, more scalable solutions in personalized medicine. What you'll learn in this episode: >> How 3D printing is enabling customized bone scaffolds and regenerative therapies >> The role of AI in optimizing pharmaceutical 3D printing parameters >> How organoids can act as micro-organs for testing and computation >> The promise and challenge of personalized, on-demand drug manufacturing >> Why collaboration between data scientists and biopharma researchers is critical Meet our guest LR Jaidev Chakka is a Principal Scientist at the University of Mississippi School of Pharmacy, pioneering 3D bioprinting, drug delivery, and organoid research to revolutionize patient care and pharma manufacturing. About the host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with Our Guest: Sponsor: CorrDyn, a data consultancyConnect with Jaidev Chakka on LinkedIn  Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode!Connect with Ross Katz on LinkedIn Sponsored by… This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

In this episode, Sterling Elliott, PharmD, BCMTMS, Clinical Pharmacist Lead, Assistant Professor of Orthopaedic Surgery at Northwestern Medicine & Affiliate Faculty Member, Purdue University College of Pharmacy, shares how pharmacists are stepping into expanded leadership roles in ambulatory and procedural care amid rising cost pressures and the shift to value based care. He discusses opioid stewardship in orthopedic surgery, innovative patient education models, and the barriers and opportunities facing pharmacists practicing at the top of their license.

As we head into 2026, independent pharmacies are facing a hard reset in how healthcare is regulated, marketed, and delivered. From tightening scrutiny around tracking and consumer health data to rising patient expectations for speed, transparency, and convenience, the rules of engagement are changing fast—and pharmacies that don't adapt risk falling behind.In this episode of the DrMarketingTips Show – Independent Pharmacy Edition, we break down the forces shaping the year ahead and what they mean for independent pharmacy owners and operators. This conversation focuses on the practical realities of privacy, patient access, logistics, and trust—and how these shifts create both risk and opportunity for pharmacies navigating an increasingly consumer-driven healthcare environment.

In this episode, our guest is Kate Campbell, PharmD, who serves as the Director of Pharmacy at Olympia Pharmacy. She is a proud alumna of the University of Florida, graduating Cum Laude with a bachelor's degree in biology and a doctorate in pharmacy. Dr. Campbell's previous work experiences in retail and hospital pharmacy have led to a passion for whole-person care and preventive medicine, prompting her shift towards compounding. In her pursuit, she has become a certified hormone replacement therapy specialist with a focus on bioidentical hormone replacement therapy for females.In her personal time, Kate loves connecting with her family and friends. She especially enjoys getting out on the water, playing pickleball and trying new restaurants.1. Opening & BackgroundKate, welcome to the show! Can you start by sharing your journey into pharmacy and what ultimately drew you toward compounding and personalized medicine?You've worked in both retail and hospital settings before moving into compounding—what gaps did you notice in traditional pharmacy that compounding helps to fill?How did your education at the University of Florida shape your path and perspective on whole-person care?2. Understanding Compounding & Regulatory LandscapeFor listeners who may not be familiar, can you explain the difference between 503A and 503B compounding pharmacies?What are some of the key compliance and quality distinctions between these two types of operations?Olympia Pharmacy operates under a 503B designation—what advantages does that provide in terms of scalability, safety, and product consistency?How do you see the role of compounding evolving as more patients seek individualized therapies?3. Hormone Replacement & Preventive MedicineYou're a certified hormone replacement therapy specialist, focusing on bioidentical hormones for women. What drew you to that niche?What are some of the biggest misconceptions about bioidentical hormone therapy?How do you personalize treatment for women across different stages of life—perimenopause, menopause, and beyond?What are the key questions women should ask their providers when considering hormone replacement therapy?4. Longevity & Wellness TrendsLongevity is becoming a buzzword in healthcare. From your vantage point, what longevity-focused products or therapies are worth the hype—and which are not?What innovations are you most excited about in the patient wellness space for the upcoming year?How is Olympia Pharmacy staying ahead of emerging trends—whether it's peptides, nootropics, or nutraceuticals?5. GLP-1s and Post-Therapy CareGLP-1 medications like semaglutide and tirzepatide have transformed weight management—but we're seeing challenges after patients discontinue them.What strategies or compounded therapies are helping patients maintain results post-GLP-1 use?How can pharmacists play a role in supporting metabolic health and sustainability beyond the initial weight-loss phase?6. Leadership, Lifestyle & Personal BalanceAs a director and pharmacist, how do you balance the science of pharmacy with the art of patient care?You've mentioned enjoying pickleball, the water, and exploring new restaurants—how do you recharge outside of work?What advice would you give to other pharmacists looking to explore nontraditional or entrepreneurial paths in pharmacy?7. ClosingWhat's next for you and Olympia Pharmacy?How can listeners connect with you or learn more about the services Olympia offers? ★ Support this podcast on Patreon ★

Minister of Climate Change and Environmental Coordination Dr. Musadiq Malik comes on the Pakistan Experience to discuss the Floods, Climate Change, Early Warning Systems, the Hybrid Regime, Balochistan, PTI vs the Writ of the State, Imran Khan's sisters being mishandled, deforestation, accountability, electric vehicles, and more.Dr. Musadik Malik holds a BS in Pharmacy from the University of the Punjab.He then went to University of Illinois, where he earned an MBA, an M.S. and a Ph.D. in Healthcare Administration and Policy.In addition, he completed a post-doctoral fellowship in Health Economics and Medical Decision Making at the University of Illinois College of Medicine.The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Karachi and Motorways6:38 Climate Change, Housing Societies and RUDA25:00 Floods, Early Warning Systems and GLOF34:00 RUDA and Flood prevention Systems44:00 Deforestation, Cutting Trees and Accountability 52:10 Siyaasi Majbooriyan and Petroleum 1:02:12 Balochistan and the Hybrid Regime1:19:00 Military Courts, Institution Strengthening and Writ of the State1:29:40 Imran Khan's sisters being manhandled and writ of the state1:35:20 Gandapur and PTI's incitement to violence1:40:15 Audience Questions

While Anna is out, Producer Justin and Producer Sophia join Raven to discuss their Christmas list progress this far into the holiday season. Producer Justin educates on the history of Tinsel.  It's back! Anna and Raven Santa Tipline! Santa needs to know who's naughty, and who's nice. Call and leave a message 24/7 and you may hear yourself on the air. Call 888-702-9646 to leave a message for the Big Guy!     NBC News Anchor Heidi Voight is temporarily co-hosting Raven while Anna is away! Raven hits Heidi with the burning questions to get to know all about her!  Heidi and Raven discuss the best Christmas gifts they ever got. Raven was the talk of the town... Heidi was the loudest.   Raven had a very memorable interaction with the pharmacist when picking up his pain relief post-surgery. They discuss what level of charm a confidential worker needs to be to test the theory of “Can I date them”.   Heidi speaks on being a news anchor for the last decade and a half, and how the career has made her closer to her community and bettered her knowledge of communication.   Producer Justin and Heidi took on the ultimate Christmas challenge- the gift wrap face off. We put the two to the test to see who has better wrapping skills with very unwrappable items around the office.   Tomorrow is the most dangerous day on the road with 90% of people this year being unprepared for Christmas. If you need to go out, save yourself and hit the stores today... time is ticking!   Finish the sentence- it's not Christmas until.... Producer Justin, Producer Sophia and Heidi all join Raven for the Christmas time must dos. Can't be the holiday season without this! 

340B Insight wants to make our podcast the best it can be. To help us succeed, we'd like to hear your thoughts. Please take just a few minutes to complete our listener survey, and we will enter you in a drawing to win a $100 gift card! To participate, please go to 340bpodcast.org/survey.With monumental movement on 340B rebates, changes in Medicare and Medicaid payments, and evolving audit priorities, 2025 has been a transformative year in the world of 340B. We sit down with 340B Health Senior Manager of Policy and Compliance Rebecca Swartz to chronicle some of the biggest developments of such an eventful year and forecast what to expect in 2026.Rebates Take ShapeSwartz says 2025 will go down as the year that a rebate model shifted from a hypothetical approach pushed by drugmakers into a fully developed model with implementation criteria. The Health Resources & Services Administration (HRSA) approved plans for 340B rebate models set to take effect in January for nine of 10 drugs subject to the 2026 Medicare maximum fair prices. Rebates for the remaining drug on that list will kick in April 1. Swartz discusses how hospitals should prepare for this pilot program, which is set to upend decades of established 340B operations and impose intense financial and logistical burdens on safety-net hospitals nationwide.Medicaid, IRA Changes Set To Impact 340B HospitalsThis year also saw massive changes to Medicaid funding as well as Medicare pay changes under the implementation of the Inflation Reduction Act (IRA). Swartz says these developments are projected to shrink safety-net hospital margins even further. Renewed congressional focus is putting 340B in a high-profile spot, with potentially significant implications for the program and hospitals in the coming months.2026 Tips for HospitalsSwartz says she's identified two areas as more of a focus for HRSA audits this year: expanded scrutiny of offsite and on-site trial balances and the ways covered entities list shipping addresses. To prepare for possible shakeups in 2026, she recommends that covered entities begin and maintain cross-functional planning across departments and closely monitor denials, delays, and other costs from new rebate programs in addition to monitoring wholesale acquisition cost (WAC) changes and contract pharmacy developments.Resources340B Health Year-in-Review Webinar: 2025 Highlights and What's on the Horizon

Over the weekend, Seán and Eric took part Hybrid Series Ireland (@hybridseriesireland on Instagram) in Athlone, Eric's first ever Hyrox event. Has Eric converted into a Hybrid Rockstar enthusiast? 00:00 Merry Christmas, Eric03:02 The Hybrid Series Ireland Experience05:52 The Challenge of Endurance Events08:49 Team Dynamics in Competition14:25 The Joy of Shared Experiences18:39 The Appeal of Hybrid Events21:58 Fitness and Competition: A Personal Journey24:46 Training Strategies for the New Year28:33 Local vs. Major Races: A Personal Perspective31:19 Dublin Half Marathon BallotYou can now get 20% off all Perform Nutrition products, including their new Electrolytes+, using the code 'AGR' at checkoutPerformNutrition.com This episode is sponsored by ULTRAPURE Laboratories and their Ultrapure Sports Recovery prducts. Ask for the ULTRAPURE Laboratories Muscle Recovery range in your local Pharmacy or Health Store or visit their new online storeUltrapurelabs.ie

On this episode of IPA's What, Why & How podcast, IPA CEO Matt Pitlick welcomes Anne Schlepphorst, Bureau Chief of Monitoring and Executive Director of the Iowa Board of Pharmacy, as well as Jillian (Jill) Kremmin, PharmD, BCPS, a compliance officer for northwest and western Iowa. Anne and Jill provide an update from the latest Board of Pharmacy meeting, specifically related to compounding. Connect with us on LinkedIn: Anne Schlepphorst Jillian Kremmin Matthew Pitlick Iowa Pharmacy Association

A woman has told how she was left lying on a hospital floor for more than five hours, vomiting and in agony, as staff walked straight past her.The 61-year-old says she was treated “appallingly” at the William Harvey in Ashford after being taken to the busy A&E via ambulance.Also in today's podcast, a landlord has smeared white paint over CCTV cameras around his pub causing more than £6,000 worth of damage. He used rollers to cover the lenses as well as sensors on car park barriers and says he was trying to protect the privacy of his customers. A charity helping women on probation to rebuild their lives has opened a new centre in Kent.Many of those who use Advance are victims of domestic abuse, caught in the criminal justice system as a result of some kind of trauma.Dozens of pharmacy customers, including many Blue Badge holders, have been fined for parking at the entrance to an industrial estate while collecting their medication.For decades, visitors have been stopping on the double yellow lines at the entrance to the London Road industrial estate in Sittingbourne while grabbing their prescriptions but they've suddenly started receiving fines. And in football, the Gillingham manager says unacceptable defensive mistakes and missed chances led to defeat at Fleetwood on Saturday.You can hear from Gareth Ainsworth, as well as midfielder Armani Little, following the 2 -1 loss.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Mark Makhinson PharmD, Senior Director of Outpatient Pharmacy at Mount Sinai Health System, discusses how digital innovation, AI driven workflows, and a modern patient facing platform are reshaping specialty pharmacy, improving access, streamlining operations, and enhancing outcomes across the health system.

What is a call? How does a person know if God is calling them to mission service? Join in a discussion as these and other questions are addressed.

Blueprint: Evidence Over "Rearrangements and Vibes" — No “SN1 Rearrangement-like Policies”Guest: Dr. Oye Owolewa, PharmDGuest Bio United Sates Representative Oye Owolewa (D-D.C.) is a dedicated public servant and community advocate committed to uplifting the voices of underserved communities. Elected in 2020 as the U.S. Representative for the District of Columbia, Rep. Owolewa made history as the first Nigerian American elected to Congress. His leadership is rooted in a passion for equity, social justice, and empowering marginalized populations. Born to Nigerian immigrant parents, Rep. Owolewa grew up in Massachusetts before moving to Washington, D.C., where he earned his Doctorate in Pharmacy from Northeastern University. His background in healthcare has fueled his advocacy for accessible and affordable healthcare, mental health resources, and economic empowerment. Prior to his role in Congress, Rep. Owolewa actively served his community through various grassroots initiatives. He worked closely with local organizations to provide educational support, mentorship, and resources for D.C. residents. His focus on youth engagement and civic education has inspired young leaders to become active participants in their communities. In Congress, Rep. Owolewa continues to champion policies that promote racial and economic equity, expand mental health support, and address systemic injustices. He is a strong advocate for D.C. statehood, ensuring that residents of the nation's capital have full representation in Congress. His legislative priorities include economic development, healthcare awareness, and youth empowerment, aiming to create opportunities and resources for all D.C. residents. With a steadfast commitment to service, Rep. Owolewa remains dedicated to improving the lives of his constituents and building a more inclusive and just society for all. Episode Summary What happens when you apply mechanistic thinking—Woodward-level rigor and Percy Julian-level ingenuity—to public policy in Washington, D.C.? In this episode of Blueprint: Inventing the Future, we speak with Dr. Oye Owolewa, PharmD, who is running for DC City Council, exploring how clinical precision and evidence-based reasoning can translate into durable solutions for STEAM education, workforce development, digital equity, mental health, and civic empowerment. We frame D.C. governance like an organic synthesis problem: stabilize intermediates, control reaction conditions, eliminate “side reactions,” and design for yield—so opportunity is not theoretical, but repeatable. Music Credit Music: Reach The Top by Shane Ivers - https://www.silvermansound.com```

Up first, Inspirogene-by-McKesson with Joe DePinto   InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty pharmacy to help manufacturers, payers, and providers navigate the complex CGT landscape. https://www.mckesson.com/business-solutions/our-businesses/inspirogene-by-mckesson/ Our featured interview: Sponsored by MatchRX The TrumpRx Playbook for Independent Pharmacies CEO of MatchRx Johny Kello co-hosts with Todd Eury featuring our guest speaker, Dae Lee, Pharm.D., Esq., CPBS. Dae is a pharmacist-attorney and a Shareholder in the FDA & Biotechnology practice at Buchanan Ingersoll & Rooney. What makes Dae especially valuable for this conversation is that he's not just reading policy from 30,000 feet — he represents pharmacies every day in high-stakes fights with PBMs, from audits and reimbursement disputes to network suspensions and terminations. So, when we talk about TrumpRx — how it works, what it could break, and what independents should do next — Dae can translate the legal and contracting reality into real-world consequences behind the counter. Connect with MatchRX: MatchRX.com Special Message from Greg Reybold with APCI, update of the "Pharmacists Fight Back Act" Connect with Greg: https://www.apcinet.com/ Next, we talk with Dr. Jessica Daley PharmD Fractional Supply Chain and Operations Executive, with Pharma Logistics, we dicuss drug shortages and strategies for 2026. Connect with Jessica: https://www.linkedin.com/in/jessicaldaley/ Last interview, a suprise message from International Pharmacy 50 Pharmacist & Author Katrina Azer, announcing her new book  https://www.katrinaazer.com/#books   The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx 

Send us a textWhat if your year-end tax plan could do more than reduce your bill… and actually strengthen the future of independent pharmacy?In this episode of The Bottom Line Pharmacy Podcast, Bonnie Bond, CPA, and Austin Murray sit down with Sonja Pagniano of the NCPA Foundation to unpack how the Foundation supports pharmacy ownership, disaster recovery, and long-term sustainability for community pharmacies.We cover:- The origin story of the NCPA Foundation- Why public understanding of independent pharmacy is a key piece of independent pharmacy's future- The Rural Pharmacy Ownership Accelerator and what it means for “pharmacy deserts”- End-of-year planning strategies pharmacy owners should consider- And more!More About Our Guest:Sonja Pagniano, is the executive director of the NCPA Foundation. Sonja leads the foundation's strategic growth including the fundraising campaigns, marketing initiatives, as well as various other projects. Throughout her career Sonja has sought to strategically support the mission of philanthropic groups such as the NCPA Foundation. She most recently served as the development manager for the Center for Disaster Philanthropy, which helps donors maximize their impact on long-term recovery from disasters through expert resources, community-driven grantmaking and philanthropic consulting services.  Prior to this position, she worked at the College of Wooster's Advancement Division as the assistant director of annual giving, and as an associate planner at the Medina County Department of Planning Services and Fair Housing in Ohio.  Sonja received her Masters of Public Administration from Kent State University. She also holds a Certified Fund Raising Executive (CFRE) certification, so she is certified in the highest standards of ethics, competence, and service to the philanthropic sector. Stay connected with Sonja and the NCPA Foundation: Sonja Pagniano LinkedInNCPA Foundation Website NCPA Foundation YouTubeNCPA Foundation LinkedInNCPA Foundation FacebookStay connected with us on social media:FacebookTwitterLinkedInScotty Sykes – CPA, CFP® LinkedInMore on this topic:Podcast: NCPA 2025 RecapPodcast: Pioneering Solutions in Remote Territories

In the final session of The Profit Playbook: Ending 2025 Like a Badass, Heather Haro is joined by Julie Crozier, RPh and Amanda Gaddy, RPh of Secure 340B to break down critical changes coming to 340B rebates and Medicare Fair Pricing (MFP) rebates in 2026. This session explains how overlapping rebates work, what changes on January 1, and what independent pharmacies must do now to protect cash flow, margins, and patient access.   **Show Notes:** 1. **Introduction** [0:00] 2. **Introduction of Secure 340B Experts** [3:27] 3. **Overview of 340B and MFP Rebates** [7:01] 4. **Detailed Explanation of Rebate Processes* [41:07] 5. **Impact of Wholesale Acquisition Cost (WAC) Decreases* [41:29] 6. **Q&A Session and Additional Clarifications* [43:48] 7. **Final Remarks and Contact Information* [46:11]     ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**

Melanie Dodd, PharmD, PhC, BCPS, FASHP, is the current President of the American Society of Health-System Pharmacists (ASHP) and the Associate Dean for Clinical Affairs and Professor at the University of New Mexico College of Pharmacy. Dr. Dodd talks through her priorities for ASHP this year, her involvement in the progressive New Mexico Society of Health-System Pharmacists, and her advice to those looking to get involved!

In this episode of Diabetes Day by Day, Drs. Neil Skolnik and Sara Wettergreen are joined by Aaron Sutton, LCSW, BCD, CAADC, to explore the unique challenges the holidays can bring when living with diabetes. They share practical strategies and offer guidance on how loved ones can provide meaningful support throughout the holiday season. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Aaron Sutton, LCSW, BCD, CAADC, Director of the Sutton Institute for Psychotherapy Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day!

In episode 70 we discuss an article about prescription stimulant misuse. Han B, Jones CM, Volkow ND, et al.Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. JAMA Psychiatry. 2025;82(6):572–581. We also discuss the ASAM toolkit for addressing problems at the pharmacy with buprenorphine, and results of the 2024 NSDUH study. ASAM:Addressing Issues at the Pharmacy with Buprenorphine Prescriptions Link to report pharmacy issues STATNews:Tobacco use, binge drinking decrease as Americans consume more marijuana, survey finds --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go tothis link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visitMI CARES. CME:https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music:composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer:Dr. Patrick Beeman A podcast fromArs Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook:@AddictionMedJC Facebook Group:Addiction Medicine Journal Club Instagram:@AddictionMedJC Threads:@AddictionMedJC YouTube:addictionmedicinejournalclub Twitter/X:@AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices

The conversation delves into the complexities of medication stability, particularly focusing on how environmental factors can affect the efficacy of pharmaceuticals. It highlights the stringent storage parameters set by pharmaceutical companies and the lack of testing in combat-simulated environments, raising concerns about medication reliability in critical situations.TakeawaysMedications can appear fine but still be ineffective.Pharmaceutical companies set strict storage parameters.Environmental factors can compromise medication efficacy.Combat-simulated environments are often not tested.Temperature and humidity control are crucial for medication.There is a need for more research on medication stability.Pharmacies must adhere to specific storage guidelines.Transportation chains must maintain climate control.The reliability of medications in emergencies is questionable.Pharmaceutical testing should include diverse environments.Chapters00:00 Understanding Medication Stability00:35 Pharmaceutical Storage Parameters and ChallengesFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care

Episode Overview: In our inaugural This Week in Pharmacy, we examine the economic, technological, and policy-driven forces transforming pharmacy practice and the U.S. drug supply chain. From hidden financial power structures and AI-enabled operations to federal policy shifts impacting biosimilars, this episode brings together three timely conversations that every pharmacy leader should hear. Segment 1: The Hidden Lender in America's Drug Supply Chain Guests: Antonio Ciaccia, President, 3 Axis Advisors Alec Ginsberg, Founder, The Drugstore Cowboy Building on Alec Ginsberg's investigative article, “The Hidden Lender in America's Drug Supply Chain,” this discussion exposes how capital flows, credit structures, and opaque financial relationships influence pharmacy viability. Ciaccia and Ginsberg break down what independent pharmacists need to understand about who truly controls leverage in the system—and why transparency matters more than ever.   Segment 2: How AI Is Transforming Pharmacy Operations Guests: Harry Travis, BS Pharm, MBA, President, The Travis Group Amanda Awe, PharmD, Clinical Product Consultant, Curatio Advisors Artificial intelligence is no longer theoretical in pharmacy—it's operational. This segment explores how AI is being deployed today to improve workflow efficiency, clinical decision-making, and patient engagement, while addressing the real-world challenges of adoption. Segment 3: Policy Watch – IRA, Trump-Era Rx Changes & Biosimilars Guest: Jessica Daley, PharmD In this special policy-focused feature, Dr. Daley unpacks upcoming IRA-related developments and potential Trump-era prescription drug policy changes, with a sharp focus on how they could impact biosimilars and the U.S. supply chain. The conversation highlights what pharmacists should watch closely as regulatory and political pressures continue to evolve.   Inside the Forces Reshaping America's Drug Supply Chain | TWIRx    Thanks to NimbleRx, PRISM by OvaryIT, and Sykes & Company for sponsorsing today's show

Send us a textFederally Qualified Health Centers (FQHCs) care for more than 30 million Americans, yet many people have never heard of them or understand how they stay afloat. A major piece of their financial survival is the 340B drug pricing program, which has quietly become one of the most important funding mechanisms in the safety net and it is under growing pressure.Scott Seidelmann, CEO of Nuvem, joins CareTalk hosts David E. Williams and John Driscoll to discuss how FQHCs serve underserved communities, why 340B has become essential to their operations, and what policy changes could make or break their ability to deliver care.

Every day, I hear patients share worries shaped by the growing wave of vaccine misinformation—questions that reveal just how overwhelming today's “infodemic” has become. In this podcast, I explore what vaccine hesitancy really looks like and how pharmacists can use empathy, strong recommendations, and meaningful dialogue to help rebuild confidence in immunization.Presenter:Mary Barna Bridgeman, PharmD, BCPS, BCGPClinical ProfessorErnest Mario School of PharmacyRutgers, The State University of New JerseyPiscataway, New JerseyInternal Medicine Clinical Pharmacy SpecialistRobert Wood Johnson University Hospital-New BrunswickNew Brunswick, New JerseyLink to full program:https://bit.ly/4oHDWZqGet access to all of our new episodes by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode 94 of Astonishing Healthcare features two members of our product team, Liya Lomsadze (Sr. Director) and Jake Mulkey (Director), who explain how building a next-generation pharmacy claim adjudication system (Judi®), known for its split-second accuracy and streamlined workflows, served as the perfect foundation for building a unified platform that now includes medical claims, and will integrate vision and dental, too. Liya and Jake explain the contrast between pharmacy's real-time nature and medical's weeks-or-months-long lag, and how this gap impacts the experience for members and providers of care. The discussion covers the challenges behind supporting complex plan designs, opportunities around automating prior authorizations with real clinical data, and benefits of reducing manual interventions that slow down or interfere with care coordination. Liya and Jake also share stories about launch day, lessons learned from pharmacy claim adjudication, and their vision for a real-time future with integrated benefits. This episode is a must listen for anyone interested in how enterprise health technology can improve health benefit administration and focus resources on what's most important: plan members' experience and improving health outcomes.Related ContentReplay – The Bridge to Better Healthcare: Uniting Medical and Pharmacy Services on One Platform to Achieve Value-Based CareAH080 - Health Benefits 101: The Importance of "Smart" Care Navigation, with Andy KageleiryMedicare Transition Benefits & How Judi®'s Modern Design Enables Faster Results and Reliable ComplianceHealth Benefits 101: The Importance of Clinical ProgramsThis Startup Hit A $3.25 Billion Valuation Building Software To Fix Drug Pricing (Forbes)For more information about Capital Rx and this episode, please visit Judi Health - Insights.

Major decreased in the price of 15 major brand name drugs will take place over the next few weeks and months. Pharmacies need to look carefully at the affected medications and plan now on how to balance inventory needs to minimize the negative effect lower WAC prices will have on reimbursement. This podcast explains the issue, outlines possible actions to take and directs listeners to a website (www.complinatrx.com) with more details and timelines.

In this episode of FrameworkFocus, we explore how artificial intelligence is reshaping long-term care pharmacy. Rick Pollick and Kyle Nilson from SoftWriters' Alpha Labs join us to discuss the industry-wide impact of AI, the benefits and challenges it presents, and how SoftWriters is bringing innovative, AI-driven workflows to life—starting with AI Order Entry Automation.

Pharmacy Radio 113 December 2025 Pharmacy Radio 113 December 2025 Welcome to episode 113 of Pharmacy Radio. I have a wonderful episode for this month featuring an amazing guest mix from Basil O'Glue in the second hour showcasing his brilliant style which is a super cool trance infused techno sound. As always, in the first hour I've got my mix of techno, trance and psy. Last month was mostly progressive and techno with no psy so this month I ramp up the tempo quickly to get some hard trance and psy in before Basil takes over! First Hour: Christopher Lawrence Knorst, RIKO & GUGGA - Unforgetable - Errorr RIKO & GUGGA - No Past, No Future - Running Clouds Ed Lopes - Transformers - Ibogatech Neumann, Konfusia - Dreamliner Express - Derailed Music SILSAN, Jaiden Wild - Enter the Void (InnerVoix Remix) - INVICTA METODI, Sisters Cap - Motivation - Set About Music Kurt Heisz - Echoes of the Abyss - KickFire Charlotte de Witte - The Realm - KNTXT A.D.H.S. - In The Dark - Exhale Ritmo, Antinomy - Coconut - Iboga Records Headroom (SA) - Origin and Tonic - Iboga Records Pixel, Squid, Attalef - Anana Vak - Iboga Records Doppler Botond - Capricorno - TechSafari records Space Cat, Pixel - Kof Tibeti - Alteza Records Official Guest Mix: Basil O'Glue Moshic & Stereo Underground - See Through Your Heart Guy J - Alive Again Jay Hubbard & An Sinewave - Path To Light (F-Act Remix) Intacto - Shadowbinder Extrawelt - Mindwear Basil O'Glue - Unnecessary Attitude (Nomas Remix) Ancestral Landscapes - Cyopheric Waves (Van Morph Remix) Frank Sonic, DIST_42 - Silberschwein MTRL,KAF - Interstellar Boundary Explorer Basil O'Glue - Pray Tell (Atlas Remix) Selective Response - Psychic Symbols Milo Raad - Below The Surface

Speakers: ● Todd Eury – CEO, The Pharmacy Podcast Network (Moderator/Host) ● Calvin Hunsicker – Co-Founder & Chief Product Officer, SureCost (Product Vision & Innovation Lens) ● Amy Cruse, Vice President, Pharmacy, AmPharm ● Marsha K. Millonig, MBA, BPharm – President & CEO, Catalyst Enterprises  –Pharmacy Industry Perspective

In this episode, Will Yin, CEO of Mandolin, discusses how AI agents are transforming specialty pharmacy workflows by reducing administrative bottlenecks, preventing costly denials, and improving access to life changing therapies while helping health systems scale operations more efficiently.This episode is sponsored by Mandolin.